TAB1 Monoclonal Antibody

    • Catalog No.:YM1101
    • Applications:WB
    • Reactivity:Human;Mouse;Rat;Bovine;Dog;Pig
      • Target:
      • TAB1
      • Fields:
      • >>MAPK signaling pathway;>>NF-kappa B signaling pathway;>>Osteoclast differentiation;>>Toll-like receptor signaling pathway;>>NOD-like receptor signaling pathway;>>TNF signaling pathway;>>Alcoholic liver disease;>>Pathogenic Escherichia coli infection;>>Shigellosis;>>Salmonella infection;>>Yersinia infection;>>Leishmaniasis;>>Toxoplasmosis;>>Hepatitis B;>>Herpes simplex virus 1 infection;>>Epstein-Barr virus infection;>>Human immunodeficiency virus 1 infection;>>Lipid and atherosclerosis
      • Gene Name:
      • TAB1
      • Protein Name:
      • TGF-beta-activated kinase 1 and MAP3K7-binding protein 1
      • Human Swiss Prot No:
      • Q15750
      • Mouse Swiss Prot No:
      • Q8CF89
      • Immunogen:
      • Purified recombinant human TAB1 (N-terminus) protein fragments expressed in E.coli.
      • Specificity:
      • TAB1 Monoclonal Antibody detects endogenous levels of TAB1 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Monoclonal, Mouse
      • Dilution:
      • WB 1:1000 - 1:2000. Not yet tested in other applications.
      • Purification:
      • Affinity purification
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • TAB1;MAP3K7IP1;TGF-beta-activated kinase 1 and MAP3K7-binding protein 1;Mitogen-activated protein kinase kinase kinase 7-interacting protein 1;TGF-beta-activated kinase 1-binding protein 1;TAK1-binding protein 1
      • Molecular Weight(Da):
      • 55kD
      • Background:
      • The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced tr
      • Function:
      • function:May be an important signaling intermediate between TGFB receptors and MAP3K7/TAK1. May play an important role in mammalian embryogenesis.,similarity:Contains 1 PP2C-like domain.,subunit:Interacts with MAP3K7, XIAP and BIRC7.,tissue specificity:Ubiquitous.,
      • Subcellular Location:
      • nucleoplasm,cytoplasm,cytosol,endosome membrane,protein complex,
      • Expression:
      • Ubiquitous.
      • Products Images
      • Western Blot analysis using TAB1 Monoclonal Antibody against K562, HeLa cell lysate.